Search research articles
Contact Us
Filters
Showing results (111-120 of 210) with videos related to
Page
of 21
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2015
A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion
C A Lago-Hernandez, H Feldman, E O'Donnell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019
Tej A Patel, Bhav Jain, Neha Vapiwala, et al.
American Journal of Clinical Oncology
|
June 6, 2019
Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis
Danielle S Bitterman, Nina N Sanford, Andrzej Niemierko, et al.
Urologic Oncology
|
October 19, 2015
Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012
Michelle D Nezolosky, Kathryn T Dinh, Vinayak Muralidhar, et al.
Urology
|
August 9, 2020
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making
Nayan Lamba, Santino Butler, Brandon A Mahal, et al.
Brachytherapy
|
April 19, 2015
Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer
Vinayak Muralidhar, Brandon A Mahal, David R Ziehr, et al.
BJU International
|
July 25, 2015
Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?
Brandon A Mahal, Vinayak Muralidhar, Yu-Wei Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level
Vinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
JCO Oncology Practice
|
January 22, 2024
Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United States
Edward Christopher Dee, Nishwant Swami, Bahaa Kazzi, et al.
Cancer
|
March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study
Brandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 210) with videos related to
Sort By:
Page
of 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 19, 2015
A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion
C A Lago-Hernandez, H Feldman, E O'Donnell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Trends in Utilization and Medicare Spending on Short-Course Radiation Therapy for Breast and Prostate Cancer: An Episode-Based Analysis From 2015 to 2019
Tej A Patel, Bhav Jain, Neha Vapiwala, et al.
American Journal of Clinical Oncology
|
June 6, 2019
Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis
Danielle S Bitterman, Nina N Sanford, Andrzej Niemierko, et al.
Urologic Oncology
|
October 19, 2015
Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012
Michelle D Nezolosky, Kathryn T Dinh, Vinayak Muralidhar, et al.
Urology
|
August 9, 2020
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-making
Nayan Lamba, Santino Butler, Brandon A Mahal, et al.
Brachytherapy
|
April 19, 2015
Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer
Vinayak Muralidhar, Brandon A Mahal, David R Ziehr, et al.
BJU International
|
July 25, 2015
Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?
Brandon A Mahal, Vinayak Muralidhar, Yu-Wei Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen Level
Vinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
JCO Oncology Practice
|
January 22, 2024
Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United States
Edward Christopher Dee, Nishwant Swami, Bahaa Kazzi, et al.
Cancer
|
March 13, 2016
National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study
Brandon A Mahal, Yu-Wei Chen, Jason A Efstathiou, et al.
Page
of 21